These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24669233)

  • 1. Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions.
    Ji Q; Huang B; Wang M; Ren Z; Zhang S; Zhang Y; Sheng L; Yu Y; Jiang J; Chen D; Ying J; Yu J; Qiu L; Wan R; Li W
    Exp Ther Med; 2014 Apr; 7(4):778-784. PubMed ID: 24669233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
    Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
    Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.
    Porcel JM; Bielsa S; Esquerda A; Ruiz-González A; Falguera M
    Eur J Intern Med; 2012 Jul; 23(5):447-50. PubMed ID: 22726374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
    Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study.
    Perlepe G; Varsamas C; Petinaki E; Antonopoulos D; Daniil Z; Gourgoulianis KI
    J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating between tuberculous and non-tuberculous pleural effusions using the pleural fluid ratio of 10× adenosine deaminase/lactate dehydrogenase.
    Li Y; Chen Z; Yang P; Duan H; He J; Gong L; Zhao L
    J Thorac Dis; 2023 May; 15(5):2627-2635. PubMed ID: 37324069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pleural fluid C-reactive protein in diagnosis of pleural effusions.
    Yilmaz Turay U; Yildirim Z; Türköz Y; Biber C; Erdoğan Y; Keyf AI; Uğurman F; Ayaz A; Ergün P; Harputluoğlu M
    Respir Med; 2000 May; 94(5):432-5. PubMed ID: 10868705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
    Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
    Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions.
    Yeo CD; Kim JW; Cho MR; Kang JY; Kim SJ; Kim YK; Lee SH; Park CK; Kim SH; Park MS; Yim HW; Park JY
    Tuberc Respir Dis (Seoul); 2013 Dec; 75(6):244-9. PubMed ID: 24416055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.
    Park DS; Kim D; Hwang KE; Hwang YR; Park C; Seol CH; Cho KH; Kim BR; Park SH; Jeong ET; Kim HR
    Yonsei Med J; 2013 Mar; 54(2):396-402. PubMed ID: 23364973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.
    Sharma A; Agrawal A; Sindhwani G; Sharma A; Tomo S; Charan J; Yadav D; Sharma P
    Pleura Peritoneum; 2021 Jun; 6(2):83-90. PubMed ID: 34179342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor.
    Wang J; Feng ZX; Ren T; Meng WY; Khan I; Fan XX; Pan HD; Liu L; Tang YJ; Yao XJ; Li RZ; Wang MF; Leung EL
    Medicine (Baltimore); 2022 Oct; 101(41):e31027. PubMed ID: 36254028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Combination of Calprotectin and CXCL12 for Predicting Malignancy in Patients with Exudative Pleural Effusion.
    Luo J; Wang M; Li C; Liang B; Liu D; Shi C; Jiang F; Wang T; Li P; Liang Z
    Medicine (Baltimore); 2015 Nov; 94(47):e2105. PubMed ID: 26632726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions.
    Watanabe N; Ishii T; Kita N; Kanaji N; Nakamura H; Nanki N; Ueda Y; Tojo Y; Kadowaki N; Bandoh S
    BMC Pulm Med; 2018 Nov; 18(1):176. PubMed ID: 30470216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of C-reactive protein in pleural fluid and serum is effective in the differential diagnosis of exudative pleural effusions.
    Qu SY; Zhang Y; Wu S; Wang MM; Liu LL; Yang XM; Shan HL; Yang JL; Chen P; Ti XY
    Ann Transl Med; 2021 Jul; 9(14):1183. PubMed ID: 34430624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of procalcitonin, C-reaction protein and carcinoembryonic antigens for discriminating between benign and malignant pleural effusions.
    Ji M; Zhu X; Dong J; Qian S; Meng F; Gu W; Qiu W
    Oncol Lett; 2018 Aug; 16(2):1727-1735. PubMed ID: 30008860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.
    Kim CH; Oh HG; Lee SY; Lim JK; Lee YH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Lee J
    Ann Transl Med; 2019 Aug; 7(16):373. PubMed ID: 31555687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
    Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
    Lung; 2006; 184(3):141-5. PubMed ID: 16902838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study.
    Cao XS; Yan L; Jiang TW; Huang JH; Chen H; Porcel JM; Zheng WQ; Hu ZD
    Ther Adv Respir Dis; 2024; 18():17534666231222333. PubMed ID: 38189269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
    Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
    Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.